DORMOCO
ActiveSummary
The computed 12-month bankruptcy probability of DORMOCO is 2.6% (moderate). The 2025 annual accounts show equity of €75,191 and a net result of €33,307. Equity is growing by about 64% per year across the filed financial years. Its solvency ranks better than 44% of 13,618 sector peers (NACE 46, financial year 2025). The company has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Ontwikkeling en productie van medisch- en tandartsmateriaal; Aankoop en verkoop van medisch- en tandartsmateriaal; Handelsbemiddeling tussen…” (deed in Dutch)
3 activities (deed in Dutch)
- Ontwikkeling en productie van medisch- en tandartsmateriaal
- Aankoop en verkoop van medisch- en tandartsmateriaal
- Handelsbemiddeling tussen medici en tandartsen en producenten van medisch- en tandartsmateriaal
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- DORMOCO
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, 2970 Schilde, Heidedreef 58” (deed in Dutch)“Vlaams Gewest, bestuursorgaan kan administratieve zetels, agentschappen, werkhuizen, stapelplaatsen en bijkantoren vestigen in België of…” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Één of meer bestuurders, natuurlijke personen of rechtspersonen, al dan niet aandeelhouder, onbepaalde duur als geen specifieke duur bepaald…” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- 30 April at 14:00